(OAMs) were treated with maximally tolerated doses of metformin and glibenclamide for at least 8 weeks and then randomized to bedtime neutral protamine Hagedorn (NPH) insulin plus maximally tolerated dose of glibenclamide BID (glib/NPH group) or insulin lispro mix 50 (50% lispro, 50% insulin ...
WNlB&FrPbHHyuvHOd# z@uOUWy{Ge(Pi%?z>QwQ^5gP|n4Xs#73IDuMhZkW~4nphDYhLa4H8ZMrW+DY*8%z)W zVIvA*k^PJ%9=dxd5~b%oS*y2D1G?7hbv3ipvej%#bEK5MolK~`&tT@>rbS-&w}ma_ zckAEGh4$?g9mwjXR-p=XUk0s{_F=H$VV3=BC=`0@ZsLM>bTg-`$1oV$*(FvL#(;R1 z!IpJC?LUO0V;sFnk9...
Body weight increased by 2.8 kg overall (p < 0.001), and by 2.3, 1.7, 1.9, and 3.3 kg on NPH, detemir, glargine and premix (p < 0.001 for all groups); insulin dose at 12 months was 0.70 (overall), 0.64, 0.61, 0.56 and 0.76 U/kg/day. After 36 months, 57% of people on ...